Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 27, 2023

SELL
$90.94 - $199.54 $4.1 Million - $9 Million
-45,087 Reduced 99.81%
86 $7,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $4.1 Million - $9.01 Million
45,130 Added 104953.49%
45,173 $4.11 Million
Q4 2022

Feb 08, 2023

BUY
$102.55 - $135.33 $4,409 - $5,819
43 New
43 $5,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Okabena Investment Services Inc Portfolio

Follow Okabena Investment Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Okabena Investment Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Okabena Investment Services Inc with notifications on news.